# GSK-spinoff Haleon forecasts 2023 organic revenue growth at top-end of view
Published: 2023-04-20
Category: Headlines
Category URL: https://companiesdigest.com/category/headlines/
Meta Title: GSK-spinoff Haleon forecasts strong revenue growth in 2023
Meta Description: Consumer healthcare group Haleon expects 2023 organic revenue growth towards the upper end of its forecast, driven by high demand and restocking of respiratory
URL: https://companiesdigest.com/gsk-spinoff-haleon-forecasts-2023-organic-revenue-growth-at-top-end-of-view/

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qsutv4003uwirgbjchzj7a/images/2023-04-20t064720z2lynxmpej3j07mrtroptp4usa-stocks-1737055516837-compressed.jpg)

# GSK-spinoff Haleon forecasts 2023 organic revenue growth at top-end of view

(Reuters) – Consumer healthcare group Haleon expects 2023 organic revenue growth towards the upper end of its 4%-6% forecast, it said on Thursday, on strong demand and the restocking of its respiratory health products due to a bad cold and flu season.

The company, the world’s biggest standalone consumer health business that sells non-prescription drugs, vitamins and oral care products, kept the rest of its full-year 2023 outlook unchanged.

Haleon was carved out of British drugmaker GSK in July last year.

(Reporting by Yadarisa Shabong in Bengaluru; Editing by Janane Venkatraman)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---